Viewing Study NCT06825559

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2025-12-26 @ 1:28 AM
Study NCT ID: NCT06825559
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2025-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Sponsor: Zydus Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cholestatic Liver Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Saroglitazar Magnesium View
None Primary Biliary Cholangitis View
None PBC View
None Pharmacokinetics View